We are live on ! Find out more
PROF

Profound Medical

39 hedge funds and large institutions have $62.8M invested in Profound Medical in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,229% more call options, than puts

Call options by funds: $3.06M | Put options by funds: $230K

3.5% less ownership

Funds ownership: 45.26%41.76% (-3.5%)

11% less funds holding

Funds holding: 4439 (-5)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

26% less capital invested

Capital invested by funds: $84.6M → $62.8M (-$21.9M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
39
Holders Change
-5
Holders Change %
-11.36%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
4
Increased
10
Reduced
12
Closed
7
Calls
$3.06M
Puts
$230K
Net Calls
+$2.83M
Net Calls Change
-$665K
Name Holding Trade Value Shares
Change
Change in
Stake
DM
1
Deerfield Management
New York
$12.5M
GS
2
Gagnon Securities
New York
$9.68M +$25.3K +3,197 +0.2%
LBA
3
Letko, Brosseau & Associates
Quebec, Canada
$8.89M -$349K -44,100 -3%
Fidelity International
4
Fidelity International
Bermuda
$7.96M +$198K +25,010 +2%
TIM
5
Timelo Investment Management
Ontario, Canada
$6.14M +$508K +64,250 +8%
RA
6
Royce & Associates
New York
$3.67M -$16.6K -2,100 -0.4%
GA
7
Gagnon Advisors
New York
$3.21M
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$2.82M +$516K +65,305 +20%
ZDA
9
Zweig-DiMenna Associates
New York
$1.87M +$115K +14,500 +6%
GGHC
10
Gilder Gagnon Howe & Co
New York
$1.07M -$132K -16,732 -10%
National Bank of Canada
11
National Bank of Canada
Quebec, Canada
$840K +$37.4K +4,727 +4%
PIC
12
PCJ Investment Counsel
Ontario, Canada
$811K
AIC
13
AWM Investment Company
New York
$626K -$2.08M -263,031 -75%
Bank of America
14
Bank of America
North Carolina
$565K -$6.94K -878 -1%
RJA
15
Raymond James & Associates
Florida
$448K +$6.6K +835 +1%
CM
16
Caption Management
Oklahoma
$446K
RJFSA
17
Raymond James Financial Services Advisors
Florida
$272K -$76.4K -9,666 -21%
TDC
18
Thompson Davis & Co
Virginia
$178K -$57.6K -7,287 -23%
MIM
19
MTM Investment Management
South Carolina
$146K -$3.95K -500 -2%
CAG
20
Crestwood Advisors Group
Massachusetts
$129K +$140K +17,700 New
HA
21
Harbor Advisors
Florida
$90K
SSA
22
Schonfeld Strategic Advisors
New York
$81K -$791 -100 -0.9%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$79K
CAN
24
Cetera Advisor Networks
California
$77K +$83.2K +10,519 New
Morgan Stanley
25
Morgan Stanley
New York
$50K -$9.27K -1,172 -15%

PROF Hedge Fund Activity: Q2 2022 in Review

39 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2022, worth a combined $62.8M — down 26% from $84.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PROF and 4 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 10 added.

The largest buyer was Royal Bank of Canada, adding an estimated $516K. The largest seller was AWM Investment Company, cutting an estimated $2.08M.

  • 39 institutional investors held Profound Medical (PROF) as of Q2 2022, down from 44 in Q1 2022.
  • Funds reported $62.8M of Profound Medical stock for Q2 2022, down 26% quarter-over-quarter.
  • 4 funds opened new Profound Medical positions in Q2 2022 and 7 closed out, a net change of -3 holders.
  • The largest Profound Medical buyer in Q2 2022 was Royal Bank of Canada, an estimated $516K added.
  • The largest Profound Medical seller in Q2 2022 was AWM Investment Company, an estimated $2.08M sold.

Based on aggregated 13F filings for Q2 2022.